3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
9
Uterine Cervical Dysplasia
8
Papillomavirus Infections
8
HIV Infections
2
Condylomata Acuminata
2
Anus Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Persistent Infection
1
Neoplasms
1
Neoplasm Metastasis
1
Keratosis, Actinic
1
Inflammatory Bowel Diseases
1
Head and Neck Neoplasms
1
Genital Human Papilloma Virus Infection
1
Endometrial Neoplasms
1
Crohn Disease
1
Colitis, Ulcerative
1
Cervical Cancer Screening
1
Carcinoma, Squamous Cell
1
Carcinoma, Basal Cell
1
Acquired Immunodeficiency Syndrome
1
Interventions
Surveys and Questionnaires
114
Exercise
103
Blood Specimen Collection
99
Radiotherapy
67
Gemcitabine
64
Bevacizumab
57
Standard of Care
56
Cisplatin
55
Cyclophosphamide
51
Capecitabine
50
Carboplatin
49
Docetaxel
47
pembrolizumab
46
Dexamethasone
46
Paclitaxel
45
Interviews as Topic
43
Oxaliplatin
40
Magnetic Resonance Spectroscopy
39
Fluorouracil
37
Methods
36
Irinotecan
36
Therapeutics
33
Drug Therapy
33
Radiosurgery
31
Nivolumab
30
Erlotinib Hydrochloride
27
Educational Status
26
Everolimus
24
Leucovorin
23
Control Groups
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms
×
Papillomavirus Vaccines
×
Clear all
NCT06686043
2024-11-13
HPV-VIM
Baylor College of Medicine
Phase 2
Recruiting
85 enrolled